Mark Vaile buys 30,000 shares at 32.5 cents. Not many shares bought but an indication to the market that VBA have turned the corner.The re rating is on. Not long until VBA is in the 40's.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ASX Market Open: Aussie investors to power past concerns raised by Trump's tariff threats | November 27, 2024